Home/Hedge Fund Intelligence/Legend Biotech Corp
Nasdaq: LEGNStockForm 13F30 Jun 2026

Hedge funds that hold Legend Biotech Corp ADS Nasdaq: LEGN

ADS · CUSIP 52490G102 · who reports it, how much, and how much it matters to them

28 of the 720 hedge fund managers we track reported shares of Legend Biotech Corp (Nasdaq: LEGN) on Form 13F for 30 June 2026. Between them they reported USD 602m. The largest position belongs to Suvretta Capital Management, at USD 204m. The manager with the most riding on it is Ivyrock Asset Management (HK), where it is 13.1% of the reported book.

Managers reporting it28of 720 we track
Value they reportUSD 602mshares only, 30 Jun 2026
Funds they run298with a file on PPLI.com
Largest positionUSD 204mSuvretta Capital Management
Typical weight0.0%median share of a manager's book
Heaviest weight13.1%Ivyrock Asset Management (HK)

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

28 managers, USD 602m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Legend Biotech Corp, largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Suvretta Capital Management4 funds on PPLI.comUSD 204m3.7%
2POINT72 Asset Management17 funds on PPLI.comUSD 89m0.1%
3Kynam Capital Management1 fund on PPLI.comUSD 87m4.8%
4Artisan Partners1 fund on PPLI.comUSD 45m0.1%
5Renaissance Technologies13 funds on PPLI.comUSD 29m0.0%
6Ivyrock Asset Management (HK)1 fund on PPLI.comUSD 23m13.1%
7ECOR1 Capital3 funds on PPLI.comUSD 23m1.1%
8Squarepoint Ops7 funds on PPLI.comUSD 22m0.0%
9Adage Capital Management1 fund on PPLI.comUSD 17m0.0%
10Arrowmark Colorado Holdings24 funds on PPLI.comUSD 10m0.4%
11Hudson Bay Capital Management8 funds on PPLI.comUSD 9.8m0.0%
12Resolute Capital Asset Partners1 fund on PPLI.comUSD 7.5m3.2%
13Burkehill Global Management5 funds on PPLI.comUSD 7.2m0.3%
14Balyasny Asset Management25 funds on PPLI.comUSD 6.1m0.0%
15Marshall Wace LLP84 funds on PPLI.comUSD 5.8m0.0%
16Polymer Capital Management (HK)1 fund on PPLI.comUSD 4.8m0.2%
17Two Sigma Investments35 funds on PPLI.comUSD 4.7m0.0%
18Citadel Advisors32 funds on PPLI.comUSD 986,0000.0%
19Rock Springs Capital Management2 funds on PPLI.comUSD 967,0000.0%
20Tudor Investment Corporation10 funds on PPLI.comUSD 839,0000.0%
21LMR Partners2 funds on PPLI.comUSD 578,0000.0%
22Engineers Gate Manager1 fund on PPLI.comUSD 543,0000.0%
23Cinctive Capital Management5 funds on PPLI.comUSD 522,0000.0%
24Jain Global1 fund on PPLI.comUSD 518,0000.0%
25Diametric Capital2 funds on PPLI.comUSD 289,0000.0%
26Persistent Asset Partners10 funds on PPLI.comUSD 277,0000.1%
27Freestone Grove Partners1 fund on PPLI.comUSD 159,0000.0%
28Bayforest Capital1 fund on PPLI.comUSD 34,5690.0%
Next: where it matters most
Where it matters most

For Ivyrock Asset Management (HK) it is 13.1% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Ivyrock Asset Management (HK)USD 23m13.1%
2Kynam Capital ManagementUSD 87m4.8%
3Suvretta Capital ManagementUSD 204m3.7%
4Resolute Capital Asset PartnersUSD 7.5m3.2%
5ECOR1 CapitalUSD 23m1.1%
6Arrowmark Colorado HoldingsUSD 10m0.4%
7Burkehill Global ManagementUSD 7.2m0.3%
8Polymer Capital Management (HK)USD 4.8m0.2%
9POINT72 Asset ManagementUSD 89m0.1%
10Persistent Asset PartnersUSD 277,0000.1%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Legend Biotech Corp

What is the ticker symbol of Legend Biotech Corp?

Legend Biotech Corp trades under the symbol LEGN on the Nasdaq. Its CUSIP, the code used on Form 13F, is 52490G102.

Which hedge funds own Legend Biotech Corp (Nasdaq: LEGN)?

28 of the 720 hedge fund managers PPLI.com tracks reported Legend Biotech Corp shares on Form 13F for 30 June 2026. The largest reported positions were held by Suvretta Capital Management (USD 204m), POINT72 Asset Management (USD 89m), Kynam Capital Management (USD 87m), Artisan Partners (USD 45m) and Renaissance Technologies (USD 29m).

How many hedge funds hold Legend Biotech Corp?

28 managers in our coverage reported it, and between them they run 298 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Legend Biotech Corp?

Ivyrock Asset Management (HK), where the position was 13.1% of the reported 13F book at 30 June 2026.

Does this show who is short Legend Biotech Corp?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Legend Biotech Corp or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.